** Shares of telehealth firm Hims & Hers HIMS.N fall 6.2% to $37.98 premarket
** Novo Nordisk NOVOb.CO says it would offer doses of its weight-loss drug Wegovy at a reduced cost of $499 per month for cash paying customers in the United States
** Wegovy has a list price of around $1,350 a month, regardless of dosage
** Discounted drugs will be distributed through a program called NovoCare Pharmacy to uninsured patients or those whose insurance does not cover obesity medicines
** HIMS has benefited from selling cheaper copies, or compounded versions, of Wegovy
** Telehealth firm's shares have nearly tripled in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。